The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment

Bun Hee Lee, Yong Ku Kim

Research output: Contribution to journalArticle

193 Citations (Scopus)

Abstract

Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalPsychiatry Investigation
Volume7
Issue number4
DOIs
Publication statusPublished - 2010 Dec 1

Fingerprint

Brain-Derived Neurotrophic Factor
Antidepressive Agents
Depression
Neuronal Plasticity
Therapeutics
Brain
Serum
Neurogenesis
Nerve Growth Factors
Hippocampus
Reference Values
Biomarkers

Keywords

  • Antidepressant
  • Brain-derived neurotrophic factor
  • Depression
  • Neuroplasticity

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. / Lee, Bun Hee; Kim, Yong Ku.

In: Psychiatry Investigation, Vol. 7, No. 4, 01.12.2010, p. 231-235.

Research output: Contribution to journalArticle

@article{9c4034cfb9fc45ee8d1d43a276a9ff07,
title = "The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment",
abstract = "Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.",
keywords = "Antidepressant, Brain-derived neurotrophic factor, Depression, Neuroplasticity",
author = "Lee, {Bun Hee} and Kim, {Yong Ku}",
year = "2010",
month = "12",
day = "1",
doi = "10.4306/pi.2010.7.4.231",
language = "English",
volume = "7",
pages = "231--235",
journal = "Psychiatry Investigation",
issn = "1738-3684",
publisher = "Korean Neuropsychiatric Association",
number = "4",

}

TY - JOUR

T1 - The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment

AU - Lee, Bun Hee

AU - Kim, Yong Ku

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.

AB - Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.

KW - Antidepressant

KW - Brain-derived neurotrophic factor

KW - Depression

KW - Neuroplasticity

UR - http://www.scopus.com/inward/record.url?scp=79551648304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551648304&partnerID=8YFLogxK

U2 - 10.4306/pi.2010.7.4.231

DO - 10.4306/pi.2010.7.4.231

M3 - Article

C2 - 21253405

AN - SCOPUS:79551648304

VL - 7

SP - 231

EP - 235

JO - Psychiatry Investigation

JF - Psychiatry Investigation

SN - 1738-3684

IS - 4

ER -